{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:36:59Z","timestamp":1764308219527,"version":"3.46.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,27]]},"DOI":"10.7759\/cureus.97980","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:35:19Z","timestamp":1764308119000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia"],"prefix":"10.7759","author":[{"given":"Tadashi","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohei","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taito","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout JD","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.  Lancet Infect Dis. 2008, 8:159-66. 10.1016\/S1473-3099(08)70041-0","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks065","article-title":"Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis","volume":"67","author":"Rottier WC","year":"2012","unstructured":"Rottier WC, Ammerlaan HS, Bonten MJ. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother. 2012, 67:1311-20. 10.1093\/jac\/dks065","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3604-x","article-title":"Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories","volume":"18","author":"Tsutsui A","year":"2018","unstructured":"Tsutsui A, Suzuki S. Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories. BMC Health Serv Res. 2018, 18:799. 10.1186\/s12913-018-3604-x","journal-title":"BMC Health Serv Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas KZ","year":"2012","unstructured":"Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother. 2012, 67:2793-803. 10.1093\/jac\/dks301","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"Kang CI","year":"2004","unstructured":"Kang CI, Kim SH, Park WB, et al.. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother. 2004, 48:4574-81. 10.1128\/AAC.48.12.4574-4581.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson ME","year":"1985","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1985, 40:373-83. 10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman ND","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, et al.. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002, 137:791-7. 10.7326\/0003-4819-137-10-200211190-00007","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01523-12","article-title":"Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-\u03b2-lactamase-producing bacteria","volume":"57","author":"Frakking FN","year":"2013","unstructured":"Frakking FN, Rottier WC, Dorigo-Zetsma JW, et al.. Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-\u03b2-lactamase-producing bacteria. Antimicrob Agents Chemother. 2013, 57:3092-9. 10.1128\/AAC.01523-12","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00213-21","article-title":"Overview of changes to the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing, m100, 31st edition","volume":"59","author":"Humphries R","year":"2021","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing, m100, 31st edition. J Clin Microbiol. 2021, 59:e0021321. 10.1128\/JCM.00213-21","journal-title":"J Clin Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00701-15","article-title":"Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-\u03b2-lactamase-producing Escherichia coli bacteremia","volume":"59","author":"Matsumura Y","year":"2015","unstructured":"Matsumura Y, Yamamoto M, Nagao M, et al.. Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-\u03b2-lactamase-producing Escherichia coli bacteremia. Antimicrob Agents Chemother. 2015, 59:5107-13. 10.1128\/AAC.00701-15","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2018.06.019","article-title":"Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan","volume":"46","author":"Hattori H","year":"2018","unstructured":"Hattori H, Maeda M, Nagatomo Y, et al.. Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan. Am J Infect Control. 2018, 46:e75-9. 10.1016\/j.ajic.2018.06.019","journal-title":"Am J Infect Control"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2217951","article-title":"Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia","volume":"12","author":"Namikawa H","year":"2023","unstructured":"Namikawa H, Imoto W, Yamada K, Tochino Y, Kaneko Y, Kakeya H, Shuto T. Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia. Emerg Microbes Infect. 2023, 12:2217951. 10.1080\/22221751.2023.2217951","journal-title":"Emerg Microbes Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul M","year":"2010","unstructured":"Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010, 54:4851-63. 10.1128\/AAC.00627-10","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","author":"Tamma PD","year":"2023","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. Clin Infect Dis. 2023, 10.1093\/cid\/ciad428","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-1952-x","article-title":"Performance of the quick Sequential (sepsis-related) Organ Failure Assessment score as a prognostic tool in infected patients outside the intensive care unit: a systematic review and meta-analysis","volume":"22","author":"Song JU","year":"2018","unstructured":"Song JU, Sin CK, Park HK, Shim SR, Lee J. Performance of the quick Sequential (sepsis-related) Organ Failure Assessment score as a prognostic tool in infected patients outside the intensive care unit: a systematic review and meta-analysis. Crit Care. 2018, 22:28. 10.1186\/s13054-018-1952-x","journal-title":"Crit Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.12.015","article-title":"A comparison of the Quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis","volume":"153","author":"Serafim R","year":"2018","unstructured":"Serafim R, Gomes JA, Salluh J, P\u00f3voa P. A comparison of the Quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest. 2018, 153:646-55. 10.1016\/j.chest.2017.12.015","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02824-14","article-title":"A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131","volume":"58","author":"Banerjee R","year":"2014","unstructured":"Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014, 58:4997-5004. 10.1128\/AAC.02824-14","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks278","article-title":"Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-\u03b2-lactamase-producing Escherichia coli in Japan","volume":"67","author":"Matsumura Y","year":"2012","unstructured":"Matsumura Y, Yamamoto M, Nagao M, et al.. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-\u03b2-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother. 2012, 67:2612-20. 10.1093\/jac\/dks278","journal-title":"J Antimicrob Chemother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2018.63","article-title":"Comparison of predictors and mortality between bloodstream infections caused by esbl-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae","volume":"39","author":"Scheuerman O","year":"2018","unstructured":"Scheuerman O, Schechner V, Carmeli Y, et al.. Comparison of predictors and mortality between bloodstream infections caused by esbl-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2018, 39:660-7. 10.1017\/ice.2018.63","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422246-prognostic-factors-and-optimal-empiric-therapy-for-extended-spectrum-beta-lactamase-esbl-producing-enterobacterales-bacteremia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:35:20Z","timestamp":1764308120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422246-prognostic-factors-and-optimal-empiric-therapy-for-extended-spectrum-beta-lactamase-esbl-producing-enterobacterales-bacteremia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.97980","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}